Nufarm Limited (NUF) Earnings Call Transcript & Summary
November 15, 2022
Earnings Call Speaker Segments
Operator
operatorWe appreciate everyone being on the line, and we’re glad to have you join the Nufarm Limited FY '22 Results Call. <<operator_script>> At this point I’ll turn the conference over to Mr. Greg Hunt, CEO. Sir, the floor is yours.
Gregory Hunt
executiveThanks, Chad, and morning, everyone. Welcome, and I appreciate you being with us on the call today. With me is our CFO, Paul Townsend. We're also joined by Rico Christensen and Brent Zacharias, whom I believe most of you are familiar with, and they'll use this chance to give an update on the growth and aspirational targets we discussed back in February this year. Before we begin, please note the disclaimer on page 3, especially the part covering forward-looking statements. This is a strong result for Nufarm, with earnings higher across every one of our operating segments. Seasonal conditions and appealing soft commodity prices have worked in our favor. That said, this result also shows what our transformation program has delivered, our deeper rather than broader focus, and the investments we've recently made in supply chain and portfolio. As the slide shows, revenues hit a record, rising 17% to AUD 3.8 billion, while EBITDA climbed 24% to AUD 447 million. Crop Protection saw better returns on the back of higher prices, and, as I mentioned earlier, our ongoing emphasis on core crops and key geographies. Earnings in Seed Technologies kept accelerating, up 26% for the period.
Gregory Hunt
executiveAnd importantly, we kept laying the groundwork for growth down the road. We're continuing to reshape the company, and we now view ourselves as more of an agricultural innovator, with technology and innovation set to matter more in shaping where our business goes next. Our work in that space moved ahead strongly over the year, including recent expansions of our biopesticides, omega-3 and bioenergy platforms. We're drawing on our existing Crop Protection and Seed market presence to speed up that growth. Because of this, we anticipate modest earnings growth in financial year '23. And I'm glad to report that we're on track to hit or beat our FY '26 growth aspirations. So the outlook for Nufarm over both the short and long term stays very positive. I've already spoken about the record earnings and revenue. Other key highlights include the working capital result, which shows the continued focus and discipline we've applied in this area. On the whole, a very positive result. Our balance sheet is strong, and we've generated positive cash flow. That has let us declare total dividends of AUD 0.10 per share, including a final dividend of AUD 0.06 per share. I'm pleased to say that every one of our operating segments delivered revenue growth during the year, and I want to stress that this result goes beyond attractive commodity prices from what you might call pre-debt.
Gregory Hunt
executiveAlthough tolling may recognize the benefit we received from higher prices, especially during the first half, what really mattered was our ability to bring new products forward, work through supply chain difficulties, keep investing for growth, and hit important milestones. Within Crop Protection, our regional sales blend and greater emphasis on products with better margins—items that fit well alongside our broad portfolio—are bringing risk down. Our sales depend more on planted acreage and weather-driven seasonal factors than on soft commodity prices directly. In Seed Technologies, the new revenue streams our innovations create are varied and carry substantial growth potential. The technologies and products receiving our investment now are not the sort anyone would have associated with Nufarm 5 years ago. Now to the segments individually: North America posted robust growth in both revenue and earnings. Demand arrived early in the first half, then drier conditions across the South and the West held demand back during the second half. Supply constraints likewise limited volume growth, and those, I'm glad to report, loosened as the year drew to a close. Launching new products drove margin improvement and a better product mix throughout the business. On top of that, the solid overall outcome mirrors the money we've put into manufacturing capacity here at home.
Gregory Hunt
executiveHaving people on the ground has helped us forge closer ties with customers. We're preparing for yet another year of ongoing expansion. USDA projections for 2023 indicate that planted areas should rise, which bolsters our confidence as we move into FY '23. We expect robust demand during the first half while channel restocking takes place ahead of the spring planting season. In Europe, we achieved strong revenue growth of 15% even after losing EUR 33 million in revenues from products deregistered during the year. We made up for that by launching new products and through organic growth. Sadly, procurement, logistics and manufacturing difficulties weighed on earnings, especially at our Wyke site. Raw material supply interruptions, mechanical problems and prolonged maintenance affected operations. Our CapEx program will progressively tackle these issues across the next 3 years. For FY '23, we anticipate <<inaudible>> deregistrations will hit revenue by EUR 21 million. Even so, just as we did this year, we think we can counter the revenue hit using what's in our current portfolio, organic growth and additional new product launches. Winter crop plantings have benefited from favorable weather, and we expect strong demand in the second quarter as preparations for spring planting begin.
Gregory Hunt
executiveAPAC had another really strong year. Revenue came in higher, margins improved, and costs went down, which together produced a 21% rise in EBITDA. We're still seeing the gains from rationalizing our manufacturing footprint and from the performance improvement efforts we've implemented over the past couple of years. At this point our clear focus is on growth and on generating synergies throughout the region. As we've said before, those synergies center on manufacturing, logistics, and portfolio. Over the course of the year we brought several higher-margin products to market. Every one of them made a positive contribution to the result. Pricing for active ingredients eased for certain of our foundational products during the second half, glyphosate in particular, though prices have since steadied, and we've begun restocking at those lower price points. Near term, conditions currently seen on the East Coast point to another favorable summer fallow and cropping program. It's too soon to forecast winter plantings with accuracy, but the indications are very encouraging for another big planting program. Further out, we keep collaborating with major local institutions, including the CSIRO and the Queensland University, so as to supplement our own resources and further build out our portfolio. And we anticipate that these developments and investments will serve as a key avenue of growth for us in this region over the coming few years.
Gregory Hunt
executiveThe results at Seeds Technologies were really encouraging. Revenue and earnings rose 25%, which showed just how strong demand is for our sorghum, sunflower and canola seed across multiple markets. Over the course of the year, we kept advancing our Nuseed omega-3 canola. To date, we have produced and sold 16,500 metric tons of Aquaterra oil since the commercial launch, serving key and repeat customers in Chile. We recently wrapped up our first commercial sale in the North American market. We remain on track to book our first sales of Nutriterra into the human supplement market within the next few weeks — another important milestone for this technology. As most of you are aware, we signed a strategic 10-year offtake agreement with BP for our Nuseed Carinata during the year. Over the past year, we have grown the planted area to more than 35,000 hectares in Argentina and Uruguay, and we recently expanded the program into the Northern Hemisphere, planting 6,000 hectares in the United States. As you know from our 2026 aspirations, Seed Technologies offers the company a very exciting and meaningful growth platform. This result extends the earnings momentum of recent years. Rico will speak to our program over the next year and give some additional detail on our growth aspirations over the next few years, including our recent Energy Cane acquisition.
Gregory Hunt
executivePaul will now walk you through our financial results.
Paul Townsend
executiveThanks, Greg, and good morning, everyone. As Greg mentioned, strong demand for our Crop Protection Seed products underpinned the financial result for the 2022 financial year. The 17% revenue increase includes sales of AUD 193 million at zero margin to Sumitomo under a Transitional Services Agreement. That compares with AUD 197 million in the prior period. Underlying EBITDA rose 24% to AUD 447 million, while underlying EBIT also grew 55% to AUD 237 million. Underlying net profit after tax also rose significantly to AUD 133 million, an increase of 118%. Statutory net profit after tax also increased 65% to AUD 107 million, and material items <<inaudible>>. Underlying net external interest fell to AUD 52 million for the 12 months ended FY '22, largely reflecting interest savings achieved from completion of the high-yield bond refinancing under total <<inaudible>>. Our underlying effective tax rate is 6.9%, and we expect that to fluctuate around the 30% mark. The average net working capital sales ratio sits at 28%, well below Nufarm's target and an improvement of 6 percentage points versus the prior corresponding period. This has been driven by our continued focus on customer terms, supply negotiations and effective stock management.
Paul Townsend
executiveWith those excellent earnings and a strong balance sheet position behind us, leverage improved again compared with a year earlier. Thanks to the positive outlook for earnings and cash flow, along with our present low leverage of 0.8x, the Directors have been able to declare a final dividend of AUD 0.06 per share. At this stage, we've chosen not to pursue any additional capital management options past the payment of this dividend for FY '22. That said, we continue to assess suitable capital management options consistent with our capital management principles, with growth remaining the focus. We stay disciplined when it comes to expense management, making sure increases are aligned with supporting our growth agenda. As the chart illustrates, the rise in SG&A is mainly tied to higher headcount and other costs linked to growth initiatives across both businesses. There were higher selling and distribution costs, largely supply chain related, CPI increases in staff costs, and a rise in employee incentive provisions tied to the strong earnings achieved. D&A expenses also went up in relation to Europe and Nuseed, plus other increases such as post-COVID rises in travel and insurance. Currency translation delivered a net benefit of AUD 5 million to our final SG&A outcome. The next chart reconciles our underlying EBITDA to free cash flow.
Paul Townsend
executiveClearly, the biggest pieces of this bridge are EBITDA and net working capital. Net working capital will get more attention on the following slide. Tax and interest payments came in at AUD 32 million and AUD 60 million, respectively, both in line with forecast, while CapEx investment of roughly AUD 160 million — PPE, price intangibles — rose mainly because of higher PPE spend that COVID had pushed back. As we flagged at the half, free cash flow generation for the full year was positive. To remind everyone, free cash flow is the cash the business generates before any distribution to shareholders — a very pleasing AUD 179 million prior to application toward growth initiatives and dividends. That result gave us the capacity to put AUD 80 million of free cash flow into growth initiatives, among them raising our investments in Enko and Crop.Zone and buying the energy cane assets from GranBio. After AUD 30 million in dividends paid to shareholders and AUD 10 million of payments under the Nufarm step-up securities, net cash flow stands at AUD 59 million, leaving us in a strong position going into FY '23. On the inventory and payables side, utilization of the supplier financing facility climbed further over the year, driven mostly by raw material price increases.
Paul Townsend
executiveThis site continues to serve as the port component in reinforcing Nufarm's ties with key raw material suppliers, which assists in locking down product suppliers amid today's constrained market conditions. Inventories rose at year-end, mainly because of price hikes in active ingredient costs. We expect -- we saw an improvement in payable days and observed a strong collections profile, with a substantial decrease in receivables days versus the prior corresponding period. Our emphasis on net working capital management has produced an effectively flat position across the past 2 years, which is an excellent result considering sales growth and supply chain constraints. The average net working capital to sales ratio, shown on the right-hand side of the chart, has fallen significantly since the prior year and now sits at 28%, well below our target range and consistent with the first half's outcome. Although this is an excellent outcome for Nufarm, our focus on net working capital will persist and must be balanced against ensuring continuity of supply given global logistics and supply chain challenges and the need to optimize our commercial relationship with our customers. Our CapEx spend is directed toward supporting our growth ambitions. As you can see, CapEx has risen significantly versus the prior year, largely owing to investments in Enko, Crop.Zone and energy cane, as mentioned earlier, and also to support organic growth.
Paul Townsend
executiveOver the course of the year, we kicked off projects at Wyke and Chicago Heights focused on making our productive capacity and efficiency measures better. Those projects will carry on across the coming 2 to 3 years and will strengthen how reliable we are, how competitive we are and where we sit in the market. Consistent with how we manage capital, we evaluate growth opportunities by looking at return on funds employed and by making sure we can see that targeted return on funds employed sitting above Nufarm's weighted average cost of capital. On a pleasing note, return on funds employed has climbed considerably compared with the prior year and now stands at 9.5%. Moving to the debt summary, as you can see, net debt and leverage have kept getting better. Leverage sits at 0.8x EBITDA on a rolling 12-month basis, below our core leverage target of 1.5x to 2x, including leases. Liquidity remains strong, with undrawn facilities at September 30 of roughly AUD 510 million and cash balances of roughly AUD 586 million. The high-yield bond refinancing has produced the interest savings we anticipated since March '22, once the move to the new arrangements was made. In FY '23, we expect interest expense to stay stable on a constant currency basis, with the savings from the high-yield bond offset by rises in interest-based rates.
Paul Townsend
executiveAfter the year-end, we announced entry into an asset-based lending credit facility — an ABL facility — for AUD 800 million, with an additional AUD 150 million available under a standby facility. Combining the high-yield bond with the ABL facility has strengthened Nufarm's capital structure by way of funding, diversification and a lengthened debt maturity profile, and so it supports our growth. In summary, our balance sheet is in great shape. We possess the capacity and the flexibility to seize opportunities as they come up and to back our growth aspirations. I will now pass things to Rico, who will walk you through our Crop Protection revenue aspirations.
Rico Christensen
executiveThanks, Paul. As Greg said before, Nufarm both adds to and gains from the move toward more sustainable agricultural solutions. We help our growers get more output from fewer inputs, and we supply products that assist them in adapting to climate change and in reducing unintended environmental effects. Innovation and technology are what will power Nufarm's sustainable growth. This slide highlights a few of the innovations and technologies we have in the works, which we shared in February at our Investor Day. We have a pipeline set to deliver across our core crops and our targeted geographies over multiple years. During the past year, our product launches did what we planned, and we remain on track to launch every scheduled NPI for financial year '23. This pipeline will keep supporting our customer relevance and back our revenue aspirations. As a reminder, all of our top 22 projects have passed proof of concepts, with an estimated market size of $6.6 billion. We no longer sit around waiting for products to come off patent. We are shaping our own future by continuing to target opportunities in the areas where we believe we can win. Over the year, we launched a number of products, including, as examples, new corn and several herbicides, such as Saracen, Tandus and Fierce EZ.
Rico Christensen
executiveThose product milestones strengthen where we sit in the market and each one added positively to the FY '22 results. What gives me confidence we're at least on track toward our 26th aspirations is what sits in the pipeline for FY '23, including some key launches — a new corn herbicide, <<inaudible>>, and DROPZONE, a proprietary herbicide shown to deliver lower drift. Those are only a few illustrations of new products and technologies whose benefits matter to customers. During the fairly brief period I've spent at Nufarm, I've been greatly impressed by the skilled and able colleagues across our global portfolio development and regulatory teams. Partnering with other technology providers and like-minded organizations to move our portfolio offer forward has also worked very well for us. That will remain a hallmark of our growth aspirations. I'd like to use this moment to mention a couple of investments I think could loom large in our future. Enko is the first. There were 3 reasons behind our investment in Enko. Reason one is growing resistance to today's Crop Protection products, which is gradually but steadily turning into a serious issue for farmers around the globe.
Rico Christensen
executiveThe second factor is the decline in innovation coming from the big R&D players, and that's largely a result of inefficiencies plus a lack of focus in how they prioritize things. They've got many options when it comes to allocating capital — seeds, traits, digital platforms, biologicals, bio-stimulants, and more — so they end up being a jack of all trades but a master of none. And finally, Enko, by using DEL, meaning DNA and coated libraries, which was created for the pharma sector, has demonstrated that when you have the right enabling technology, innovation can be delivered more quickly, at lower cost, and with a better chance of success. Our investment in Crop.Zone came about for much the same reasons. At present, weeds are managed in 4 different ways: chemistry, mechanical control, annual control, and biological control. Crop.Zone stands out as completely unique in that it brings together a conductive liquid with mechanical control in a sustainable way, and it's approved for organic farming. It offers an alternative, economically viable long-term answer for controlling herbicide-resistant super weeds. As Greg said earlier, these developments are exciting, and they aren't the kind of technologies you would have anticipated from Nufarm historically. They are, though, illustrations of the technologies that are going to power our future. I'll now pass things over to Brent, who will speak to -- more about some exciting growth opportunities.
Brent Zacharias
executiveYes. Thanks, Rico, and good morning to all of you. Greg has already walked you through the main highlights from this year's results, so my remarks will lean more toward growth and the outlook. Back in February, I laid out what we aspire to achieve in the Seed Technologies business over the medium to long term. Today I'm glad to report that we are well on track to meet or beat the internal targets that underpin those aspirations. Our confidence in continued strong growth comes from the accelerating pace of technology and market adoption, both at the farm gate and among our downstream customers. So turning to the outlook for our core seeds platform: market conditions stay positive for global oilseeds and for our positions in canola and sunflower. Rising worldwide demand for oil seeds, together with the conflict in Eastern Europe, is fueling greater sunflower demand in North and South America and stronger canola demand in North and South America and Australia, all of which line up with Nuseed's positions of strength and will further support our growth. Nuseed also intends to keep growing share and value from our global position in sorghum as we extend our leading ultra-early animal nutrition and bioenergy traits within the crop.
Brent Zacharias
executiveTo sum up, our seeds portfolio is highly strategic, carries a robust growth profile, and should stay a very significant piece of delivering on our growth ambitions. Turning now to omega-3: with strong technology adoption already established among leading industry players, we're now sharply focused on growing share with existing customers, while we keep scaling operations, widening our margins, and securing additional import market approvals as the key outcomes for the coming 2 to 4 years. We expect market adoption to keep scaling in our current Chilean and North American markets, and we also intend to move into additional geographies and other aquaculture species within the 2026 timeframe. With the adoption trajectory now established, we plan to raise market adoption and produce over 16,500 metric tons of oil in calendar year '23. After calendar year '23, we'll keep accelerating both market adoption and production of Aquaterra. Our demand trajectory keeps us on track to hit or beat our internal targets for what the omega-3 platform contributes to our stated 2026 aspiration. The Nutriterra launch remains on track, with our first order anticipated within the next few weeks, and we're positioned for growth in FY '23 and beyond.
Brent Zacharias
executiveOver the coming 2 to 3 years, our plan is to broaden the customer pipeline, boost sales and market share across North America, and move into additional markets as further regulatory approvals come through. Now, on the outlook for our Bioenergy platform: at present, Nuseed Carinata serves as a drop-in feedstock solution for Europe's regulated renewable fuel market. In the next few years, we also aim to reach the valuable low-carbon renewable fuels market in the United States. Given the success we are seeing from the 2022 harvest, the advantages of our new hybrid technology, and rising grower adoption of Nuseed Carinata, we anticipate at least doubling the hectares planted in FY '23, to greater than 80,000 hectares. The Carinata trajectory remains on track to meet or surpass the contribution Carinata must deliver for us to achieve our 2026 seed technology aspirations. The newest technology in Nuseed's Bioenergy platform, energy cane, offers a significant opportunity to advance -- to enable advanced agriculture feedstock generation for the energy transition, including a significant productivity boost for the existing Brazilian sugarcane biofuel industry. Research shows that, with existing 1G mill infrastructure, energy cane can raise ethanol output by 20% to 30% per hectare and boost bioelectricity generation by 2x to 4x in degraded soil areas that are less suitable for primary crops.
Brent Zacharias
executiveLooking ahead 2 to 3 years, our goal is to finish developing and bring to market these next-generation products within the acquired pipeline. On top of that, pairing energy cane with advanced 2G processing could potentially yield net zero ethanol, biogas, bio electricity, green industrial products, and low-carbon feedstocks for sustainable aviation fuel. During FY '23, we'll be pushing our research, development and commercial teams forward to drive further adoption of existing products and to demonstrate the next-generation products in the pipeline. In summary, FY '22 was a very strong year. Taken together, our financial results, strategic accomplishments and growth outlook all show that we're on track to deliver on or exceed the AUD 600 million to AUD 700 million revenue aspiration by FY '26 at 20% to 25% EBITDA margins, as we stated in February. Thank you. I'll now hand back to Greg.
Gregory Hunt
executiveThanks, Brent and Rico. I suppose that although parts of what Rico and Brent said don't really tie straight into the FY '22 result, it does highlight why we feel confident that we're on course to hit or beat our FY '26 revenue aspirations. By now we've posted several periods of sustained growth, and we think we've laid the groundwork and put the building blocks in place to keep that growth going. On a macro level, the drivers behind our business are still very favorable. Worldwide food demand is going to climb substantially as the global population grows. At the same time, pressure is mounting to satisfy our food requirements in a more sustainable way. Progress in science and technology is transforming how we employ land and plants to provide not only food, but also energy and a broad array of other new products. And Nufarm sits at the leading edge of these challenges, and a big part of that comes down to our emphasis on innovation and technology. We think demand for our products will keep expanding and propel our revenues. We have the balance sheet strength needed to deliver this growth and to capitalize on any opportunities that may come up. As for the near term, the outlook is still positive.
Gregory Hunt
executiveWe turned in a really robust outcome for financial year '22, and we think it's possible to achieve modest growth in underlying EBITDA on a constant currency basis once more in FY '23 — provided, naturally, that seasonal conditions are normal. That said, full year earnings should be weighted proportionately toward the first half, though with less skew than in FY '22. During the first 6 weeks of the new financial year, favorable seasonal conditions have persisted across most key grain-growing regions, and the outlook for soft commodity prices is still positive. Such conditions will probably underpin sustained robust demand for Seeds and Crop Protection products. With supply conditions easing and channel inventories higher than at the same point a year ago, we do not anticipate the same degree of pull-forward sales as we saw in the first half of last year. To sum up, we have a clear plan for growth. Our growth aspirations have been shared with you, and we remain on track to meet or exceed them. This year we have produced a very good result, and it builds on momentum from earlier periods. We have begun financial year '23 with positive trading conditions in every one of our business segments. With that, I'll pass things back to Chad, and we can take some questions.
Operator
operator<<operator_script>> Our first question comes from Belinda Moore of Morgans.
Belinda Moore
analystGreg and everyone else at Nufarm, well done on a strong result today. Greg, moving to the outlook — could you describe how you're viewing the cropping picture globally at the moment, but in particular, could you hone in on Australia and the recent weather and slides, kind of a near-term negative followed by a positive? And then as well, could you speak to what sort of percentage skew we should perhaps expect between the first half and second half of '23?
Gregory Hunt
executiveAppreciate that question, Belinda, and good morning. Let me start with Australia, since I can understand how it might be creating some confusion or uncertainty. I suppose the near-term effect is twofold: it poses a challenge for the winter crop harvest, though that has little to no impact on Nufarm, and of course it affects the prospects for financing the summer crop — the summer crop for '22, '23. And I guess the real pain point there is Northern New South Wales. There's certainly plenty of activity in the Darling Downs and Central Queensland. And the latest estimates have us expecting a summer crop of about 1.5 million hectares. But again, I'd point out that this isn't really material to Nufarm, because our prospects are more around the hectares of summer fellow. That's a country that's held over for the winter crop in 2023. It's actually a much bigger opportunity. In fact, we estimate that the summer fellow hectares is probably closer to 5 million. So that's 3x, 4x the size of the summer crop, which is mainly sorghum and canola. So we would see summer weed spraying in Victoria, South Australia and WA, on the back of the rainfall we've had, as being pretty strong.
Gregory Hunt
executiveAt a worldwide level, I'd say grain and oilseed inventories are still quite tight. The most recent USDA figures, I believe, point to global lending stocks excluding China being the smallest they've been since 2013, and stock-to-use ratios across the world sitting at nearly their lowest level in 20 years. So, given the uncertainty around Ukraine and Russia, we expect that to keep grain and oilseed prices healthy right through 2023, which really encourages farmers everywhere to keep investing in their crops so they can improve yields. And I suppose that's the role we play. In the U.S., certainly, projections show planted area rising by roughly 1%, which includes a 4% increase in corn acres planted here in Australia. One upside of the rain we've received is that strong soil moisture, especially on the East Coast, is likely to support a fairly large planting program for the winter crop. And in Europe, although weather conditions have been somewhat mixed over the last sort of 3 months, we've certainly seen them improve and they're now much more favorable for winter cereal planting. So overall, we think we're in a reasonably good position, Belinda.
Gregory Hunt
executiveAnd on a half-over-half basis, I’d say the best lens is probably this — and naturally it differs by region. Still, at an overall level, if you consider the kind of split we saw in ’21, that likely gives a better signal for what ’23 will look like. As I mentioned, ’23 will definitely be less concentrated in the first half than ’22 was. So it should be closer to the pattern we had in ’21.
Operator
operatorMoving on, our following question comes from Grant Saligari of Credit Suisse.
Grant Saligari
analystOn omega-3, just the first one. Brent, from what you said, I may have misread the remarks about margin expansion — it sounded like omega-3 could have been at breakeven or perhaps a bit profitable this year. So could you clear that up? And also, what volume of omega-3 did you produce in FY '22, please?
Brent Zacharias
executiveAbsolutely. Thanks, Grant — that's a good question. So on omega-3, what I can tell you is that we're happy to see our margins in the program expanding compared with a year ago. And I think that reflects both the marketplace and the appreciation of fish oil pricing, plus the market continuing to strengthen after COVID. So our margins — gross margins from that technology — keep rising and are fully on track. So hopefully that answers your question. When it comes to volumes produced, we're really looking at — and you can probably tell from my commentary — we've been through a stretch now over the past 2 or 3 years where we produced volume and then sold at that 1,500 tonnes, and what we're really focused on now in our activity as we go into FY '23 is — I guess another way of putting what we're trying to do is to produce enough volume in '23 to satisfy as much demand and to create as much demand on an annual basis as what we've seen cumulatively from everything we've done so far.
Grant Saligari
analystThat does help. And Greg, for my second question, if I may, regarding North America, could you lay out some building blocks as a bridge for the second half, since second-half EBITDA came in below even the prior '20? My guess is that some of it may have been pulled forward into the first half. Still, I wanted to ask whether you could provide some building blocks around that, and also for '23, what your expectations are on whether volume can keep growing in the North American market, please?
Gregory Hunt
executiveYes, and I appreciate the question. To be sure, as we noted in the remarks, robust demand early in the season was followed by drier weather in the latter half. So we definitely saw some demand for. We couldn't supply all the product we would have liked, and we've decided to shift earlier, so at present we're holding elevated inventory levels in North America, since channel stocks in '22 were low. They remain relatively tight, though above what we saw a year ago. Demand in October and November across North America is very strong. And we'd anticipate probably a split in '23 similar to what we saw in '22, with demand very strong right now.
Operator
operatorRichard Johnson of Jefferies has our next question.
Richard Johnson
analystGreg, I’d really like to hear your perspective on Crop Protection selling prices, broadly speaking, across different regions—and then, more specifically, what you believe has driven the positive trend. Also, given what you said about some ingredient pricing easing, how should we be thinking about that moving forward? And then, taking all of that into account, what price assumption have you built into your ’26 assumptions?
Gregory Hunt
executiveYes. Well, I’ll address that point first. Gross margins have definitely come back—as we enter ’23—to more normal levels, really after, to some degree, the one-off gains we had in ’22. But that was mostly in Australia, and it was mostly glyphosate. It has been the most volatile active ingredient. But we’ve shifted most or all of that higher-priced cost, say, in Australia. And I think, as I said, we will likely see a revision toward more normal margins. So margins like those we would have seen through ’20 and ’21 as we enter ’23. But regarding overall demand, as I said, when you look at the forecast for planted acres, hectares, depending on which geography, demand is very, very strong. And with continued high prices for—or attractive prices for—soft commodities, we would expect that demand to continue.
Richard Johnson
analystAlright, and last thing — just to be clear about Europe, I want to confirm I've got your point right: for '23, you're expecting to roughly repeat the same performance. What I'd like to understand is how the margins compare between the business that falls away and the revenue that replaces it.
Gregory Hunt
executiveI believe we discussed last year something like AUD 30-odd-million of margin — sorry, revenue impact, EUR 33 million. And beginning in '23, that impact is likely to come to roughly EUR 21 million of revenue. My expectation is that this would land somewhere in a range of EUR 10 million to EUR 12 million in gross margin. And as I mentioned, just as we did this year in '22, we would expect to offset it through organic growth as well as new product introductions.
Operator
operatorOur following question comes from Ben Wedd of Macquarie Capital.
Ben Wedd
analystNice job on the results. I just have one quick question about the guidance you issued for EBITDA growth at constant currency. Could you discuss any assumptions you baked in when hedging <<inaudible>> around currency, given that the first half of FY '23 looks like it might come in considerably below FY '22?
Paul Townsend
executiveYes. The constant currency assumptions we've used are in the Appendix. So that's the reason we can't predict what currency will do. Obviously, FY '23. So that's why, in September, we set out our statement to make it very clear that we expect modest EBITDA growth on a constant currency basis. So those rates are actually in the appendices.
Gregory Hunt
executiveApologies, I’ll just add this: regarding the split, which I believe was the second part of your question, as I mentioned before, if you look at how it broke down in ’21, at the group level it was 65% in the first half and 35% in the second half. That varies by geography. And that’s probably how you should think about the split in ’23. In ’22, of course, it was roughly 75%, 25%. So it was much more heavily weighted toward the first half. I don’t think we’ll see that same split in ’23. So closer to 65%, 35%.
Ben Wedd
analystThanks. Maybe a wider question, then, about Carinata and the carbon credit side of things. I wonder if you could say a bit about the assumptions you're making there and what you expect for carbon pricing as we head into '23, '24 and past that.
Brent Zacharias
executiveYes. Thanks, Ben. This is Brent. Yes, so the key thing I think you should grasp is that Carinata, thanks to how we can certify it and construct the data package surrounding it, can actually be qualified for sale into the regulated markets that carry high value. So as of today, as I believe I may have said earlier, we are selling into Europe's regulated market under the Renewable Energy Directive. So that is a market of very high value, as is the U.S. market, especially California, and that is an expansion market we intend to move into next. So the difficulty, naturally, is that Europe's regulated markets are not especially transparent when it comes to simply being able to glance at the values — if you were to check the California Air Resources Board dashboard, which is an online reporting system, they do report the carbon values for that kind of regulated renewable fuel program, and over this last year those have traded between $100 and $200 per ton for actual carbon. And I would simply note that the European markets, the most valuable ones in Europe, generally trade above that level. And sorry, I think just to build on the second part of your question, given the demand we are seeing around the energy transition and the number of HVO facilities, the hydrotreating vegetable oil facilities, that are coming online across the globe, it is our expectation that over time this will keep rising in the regulated markets that are most valuable.
Operator
operatorSteve Byrne with Bank of America has our next question.
Steve Byrne
analystYes, thanks. Looking ahead to your coming fiscal year, can you give any estimate of the amount of deflation you expect to see in raw material costs?
Paul Townsend
executiveOn the pricing side, whether those effects get passed along to customers or absorbed by us as a lower selling price, they net out, so in effect deflation doesn't hit us. Still, we definitely have certain estimates in which we observe AI prices declining, and we build that into our forward forecast. I think Greg discussed the underlying assumptions behind our favorable conditions supporting pricing, which means we believe the position we're taking in our forward view is a robust one.
Steve Byrne
analystSo if I'm hearing you right, you expect profit per unit to remain level, and the decline in raw material costs won't translate into a wider margin. Your pricing will come down in line with that raw material cost deflation.
Paul Townsend
executiveCorrect. Indeed. As for margins, the relative ones stay intact.
Steve Byrne
analystRight. There's no way to keep that price unless you give it back.
Paul Townsend
executiveSure, I believe there's always a chance when you're new in commercial discussions, though I suppose we should be somewhat cautious in how we frame our forward outlook.
Steve Byrne
analystAnd a quick question about Carinata. As I understand it, this is a winter crop. Could you say whether the crush infrastructure we already have works for crushing Carinata, or would those plants need modifications in order to extract the oil from Carinata? And could you also comment on how much oil per acre this crop can yield?
Gregory Hunt
executiveYes. Thanks, Steve. So it has indeed expanded as a cover crop, normally during the winter season, and that is how we are currently cultivating it in Latin America, along with the new plantings we are establishing in the Southeast and South Texas area of the U.S. By now we have completed 3 years of commercial crush with it. We have been partnering with commercial crushers, Saint Paul in particular as a European crusher, and we can move it directly into most facilities that already crush canola or, in many cases, sunflowers. So it drops right in at those commercial-type crush facilities, with some specific operating procedures that we assist them with. But it can readily go into those. The second part of your question is how much oil are we seeing? As I think I may have mentioned, we launched this year a full launch of now moving Carinata to hybrid technology. And we are right in the middle of our harvest in Latin America of that first hybrid crop, and we are seeing fantastic yield results, certainly genetic potential to push beyond 2 metric tons per hectare of grain, and the oil yield out of it is almost 50%.
Gregory Hunt
executiveYou get really, really near 1,000 kilograms of oil for each hectare, provided the environmental conditions line up.
Operator
operatorOur next question comes from Jonathan Snape at Bell Potter.
Jonathan Snape
analystIs my audio coming through clearly?
Gregory Hunt
executiveAll right, thank you, Jonathan.
Jonathan Snape
analystCould I just ask a single question about inventories — specifically, in Note 16, there's a fairly substantial increase in the provision for obsolescent stock; I believe it rose from roughly 19 million to around 58 million during this year. I'd like to check, first, whether that was charged against this year's profit figure? And second, I suppose, is that reducing the carrying value of stock down to where the market sits for actives that you intend to sell next year?
Paul Townsend
executiveYes. Okay. A few points on that. The first part of your question is about the higher-priced inventory. When you exclude the material item — the write-down of inventory for Russia and Ukraine, which was AUD 16 million — plus we also have a residual amount for the glyphosate provision where we took a writedown at March 31. That's roughly AUD 7 million or AUD 8 million. So let's say AUD 25 million. Remove that from your AUD 54 million, and you're left with a provision of about 2%, which is normal — looking at last year, it's a very typical provision for obsolescence that we carry. The growth, if you will, really stems from increased pricing in inventory. So if you normalize for the glyphosate provision and the material item, it's fairly standard.
Jonathan Snape
analystOkay, thanks. Great. And look, can I just check something on seeds, just to confirm the figures still stand. On Carinata, 80,000 hectares. I believe you said it was AUD 100 per hectare on the seed sale back at the Strategy Day. Should we still be thinking about it that way when it comes to revenue?
Brent Zacharias
executiveYes. Thanks, Jonathan. So our Carinata business model has 2 revenue streams. Seed sales make up the first, and that's correct. Roughly speaking, we'd expect about AUD 100 per hectare in revenue from selling seed to the farm at the front end of the contract. Then second, there's the part tied to the crop's carbon value, which we certify through a third party — they use RSB, roundtable sustainable biomaterials, to audit us — and we issue a sustainability certificate downstream that follows right from each field all the way through to the fuel consumption of the oil produced from it, showing we can achieve greater than 100% greenhouse gas reduction. That brings another substantial value stream from the downstream side for Carinata. So that's the other element we keep growing into with this business, and from a value and earnings standpoint, it's probably, from what I could say, much more valuable to us than the seed sale.
Jonathan Snape
analystSo you're saying that acreage is going up twofold compared with a year earlier?
Brent Zacharias
executiveCorrect. So last year, our goal was more than 40,000 hectares overall, and now we’re moving toward—targeting over 80,000 hectares for planting in FY ’23.
Jonathan Snape
analystAll right, and since we're discussing oil seeds, that 16,500 tonnes — if I check the prices, say soybean oil, it's roughly 2 grams per tonne, I suppose, and if I considered fish oil omega-3, it's somewhere between 4,000 and 4,500. What's the right way for us to think about omega-3 pricing? You're clearly working to enter the market, so my assumption is it won't match the levels at which fish oil trades or even the omega-3 products. Is it somewhere in between? Is it nearer to soy and canola, or is it closer to—
Brent Zacharias
executiveSure, I might be able to add a few thoughts on that, Jonathan. If you look at the market that's simplest to benchmark or examine, it's the Peruvian fish oil market. During the past year, it recorded trades ranging from $3,200 per metric ton to $4,000 per metric ton. What you have to keep in mind about that market, though, is that frequently the posted figures tend to be for smaller volumes in human health, and there is — we know that for large bulk volumes headed to aquaculture, it trades a bit below that level. Beyond that, several other fish oil sources exist that have lower content and trade far under <<inaudible>>. So on average, we estimate that in 2022, the weighted average across all global fish oil going into the entire aquaculture market probably traded in a range nearer $2,400 to $3,000 a tonne. That, then, is genuinely the competitive market we operate in. With Aquaterra, we've established a premium value position thanks to its sustainability and fish oil benefits compared with that market. And we trade — we typically aim to price at a modest premium over the incumbent, which is fish oil, to that $2,400 to $3,000 range.
Brent Zacharias
executiveThere are also some tweaks tied to the total omega-3 level, but that likely puts you closer to a rough estimate of what our product is relatively worth.
Jonathan Snape
analystAnd I suppose, looking at that business, the oil you're selling this year comes from last year's acreage — I can't recall the figure, but I believe it was around 20,000 acres or something like that which went in. What's the plan or the discovery regarding acres going in this year, which would probably then support the '24 oil sales program?
Brent Zacharias
executiveYes. So, as I said, we are scaling up considerably. We have launched hybrids, or are in the process of launching them, for the '23 planting season. In 2022, we actually planted more than the figure you just mentioned. But the way I would ask everyone to frame it is that in this instance, how many acres we plant matters far less — what we are most focused on is the pace of market adoption among our customers, and then we intend to match that. And what sets omega-3 apart from Carinata is that growers already know how to grow canola, and we can access those acres, which is why we have indicated more in terms of the types of volumes as a minimum that we want to aim toward, which differs from Carinata and the fact that you are persuading and assisting growers in adopting a brand-new technology. And of course, we have the very large offtake agreement with BP. So with Carinata, it is all about how many hectares we can plant based on market adoption at the farm gate. With omega-3, it is much more about how many metric tons of demand we can generate at the — in the downstream and growing along with market adoption in aquaculture.
Operator
operatorWe'll take our next question from Evan Karatzas at UBS.
Evan Karatzas
analystThat's clearly a strong outcome, but Paul, could you elaborate a bit on what you said about capital management during your prepared remarks? I might have heard it wrong, so what exactly are you potentially looking into there?
Paul Townsend
executiveYes. I think the point we're making, Evan, is that clearly, given the leverage we have, we're going to begin examining what options are available to us. But growth is a priority, and there are certain growth initiatives we're also considering. So it's something we're weighing up as to whether we take some action on the capital management front. It's — I suppose what we're getting at is that we're very attuned to it, in the sense that we — it represents an opportunity. But that said, there are some growth opportunities we're looking at as well, and for those principles, that takes precedence over any capital management. So you'll be hearing more from us over the course of the next half.
Evan Karatzas
analystAlright. Alright, great. And then just briefly regarding that product deregistration headwind in '23. Of course, we appreciate that disclosure. Could you remind us, generally speaking, whether that figure begins to taper off in FY '24? I simply can't recall the precise sequencing there. Any kind of detail you could give on the amount after FY '23?
Paul Townsend
executiveYes. Thanks, Evan. There will be additional amounts in '24 and '25, though considerably smaller. We would likely be discussing an effect of roughly EUR 3 million or EUR 4 million in '24, speaking in margin terms now, and perhaps a comparable figure in '25. And we are not — we are really mostly finished with all of it in — by the close of FY '25.
Operator
operatorThat wraps up the Q&A portion, everyone, and that brings today's call to a close. Many thanks for being with us. At this point, you're free to hang up your lines. Take care.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Nufarm Limited transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Nufarm Limited earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Nufarm Limited or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.